Transaction · 0001936799-26-000003

Sumner Michael John

Sumner Michael John, CMO, reported a transaction classified as grant at INOVIO PHARMACEUTICALS, INC. involving 29608.000000 shares for an estimated $0.00. Reported holdings after the transaction were 29608.000000 shares. A 10b5-1 reference was not detected in the stored filing text.

grantSEC transaction code ACMO
INOINOVIO PHARMACEUTICALS, INC.
Filing timeMar 05
Trade dateMar 04, 2026
Filing · SECView on SEC
InsiderProfile
% of reported position tradedUnavailableNot calculated for derivative securities.

Row-level estimate for this security and ownership context, not the insider’s complete portfolio. Joint ownership, other transactions in the filing, amendments and footnotes can affect interpretation.

Price performance since filing

Close on the filing date, the pre-filing context, and the forward return at standard windows
Price at filing
$1.68
Pre-filing
1mo ago +1.2%1w ago +10.1%1d ago +0.0%
Returns since
7d +0.0%30d -33.3%90d -32.7%180d -24.4%1y

INO price since this filing

30 days of pre-filing context and vertical markers at the filing date plus 7d / 30d / 90d / 180d / 1y afterwards
INO since 2026-03-05Filed 206 days ago · 30 days of pre-filing context shaded
Loading…
Filing datePost-filing windows (7d, 30d, 90d, 180d, 1y)30 days of pre-filing context

Transaction facts

Stored Form 4 columns with their raw values

Derivative
Type
grant
Code A
Identifier
0001936799-26-000003
Restricted Stock Unit
Transaction date
Mar 04, 2026
Filed Mar 05, 2026, 12:00 AM · 1d delay
Shares
29.6k sh
$0.00 per share
Estimated value
$0
Computed from shares × price
Holdings after
29.6k sh
Direct

Filing signal explanations

Badges describe filing facts only — not predictions.

Cluster 14dRepeat 30dPattern $100kLarge $1.00M
Derivative Transaction Direct Ownership Large Holdings Increase
-6score
Filing-only score

-6

Compact filing score computed from stored Form 4 facts. Version v1.

Mixed or weak signal

This filing has a negative filing-only score. It may be less informative as an insider-activity signal and needs extra context.

Reported relationships & other filings

Form 4 relationship flags and nearby filing context

Reported roles

Chief Medical Officer

Officer YesDirector No10% NoOther No
Footnotes & amended
  1. F1

    The vesting schedule for the 36,832 options granted on March 4, 2026 was as follows: 12,278 shares will vest on February 26, 2027; 12,277 shares will vest on February 26, 2028; 12,277 shares will vest…

  2. F2

    Each restricted stock unit represents a contingent right to receive one share of common stock. The vesting schedule for the 29,608 restricted stock units granted on March 4, 2026 was as follows: 9,870…

Original filing · 0001936799-26-000003
Related transactions

0 other filings

Same reporting owner
Recent company activity

0 recent txs

INO